Table 1:
Sample characteristics stratified by cluster among MSM in Nigeria
| Characteristics | Not in a Cluster | In a cluster | Total | P-value1 | RDS-Adjusted |
|---|---|---|---|---|---|
| N=264(63.3%) | N=153(36.7%) | N=417(100%) | P-value2 | ||
| Categorical | N (%) | N (%) | N (%) | ||
| Gender Identity | |||||
| Male | 199(75.4%) | 125(81.7%) | 324(77.7%) | 0.12 | 0.41 |
| Transgender Women | 35(13.3%) | 19(12.4%) | 54(13.0%) | ||
| Both Male and Female | 29(11.0%) | 8(5.2%) | 37(8.9%) | ||
| Age | 0.07 | 0.60 | |||
| 16–19 | 27(10.2%) | 24(15.7%) | 51(12.2%) | ||
| 20–24 | 109(41.3%) | 71(46.4%) | 180(43.2%) | ||
| >=25 | 127(48.1%) | 58(37.9%) | 185(44.4%) | ||
| Male Partners | 0.81 | 0.42 | |||
| <=1 | 149(56.4%) | 88(57.5%) | 237(56.8%) | ||
| >1 | 114(43.2%) | 64(41.8%) | 178(42.7%) | ||
| ART use | 0.07 | 0.50 | |||
| ART Experienced | 32(12.1%) | 10(6.5%) | 42(10.1%) | ||
| ART Inexperienced | 231(87.5%) | 141(92.3%) | 372(89.2%) | ||
| Education | 0.71 | 0.56 | |||
| Above High School | 235(89.0%) | 141(92.2%) | 376(90.2%) | ||
| Less than High School | 23(8.7%) | 12(7.8%) | 35(8.4%) | ||
| Missing | 6(2.3%) | 0(0.0%) | 6(1.4%) | ||
| Religion | 0.09 | 0.71 | |||
| Christianity | 192(72.7%) | 123(80.4%) | 315(75.5%) | ||
| Muslim or Atheist | 71(26.9%) | 30(19.6%) | 101(24.2%) | ||
| Occupation | |||||
| Employed | 202(76.5%) | 111(72.5%) | 313(75.1%) | 0.25 | 0.53 |
| Unemployed | 57(21.6%) | 41(26.8%) | 98(23.5%) | ||
| Missing | 5(1.9%) | 1(0.7%) | 6(1.4%) | ||
| Consistent Condom Use | |||||
| Always | 95(36.0%) | 44(28.8%) | 139(33.3%) | 0.12 | 0.65 |
| Not Always | 165(62.5%) | 108(70.6%) | 273(65.5%) | ||
| Missing | 4(1.5%) | 1(0.7%) | 5(1.2%) | ||
| STIs | |||||
| No other STIs | 73(27.7%) | 34(22.2%) | 107(25.7%) | 0.14 | 0.93 |
| Have other STIs | 163(61.7%) | 108(70.6%) | 271(65.0%) | ||
| Missing | 28(10.6%) | 11(7.2%) | 39(9.4%) | ||
| Female Partner | |||||
| No Female Partner | 130(49.2%) | 95(62.1%) | 277(66.4%) | 0.01 | <0.01 |
| Have Female Partner | 133(50.4%) | 57(37.3%) | 190(45.6%) | ||
| Sexual Orientation | 0.45 | 0.28 | |||
| Gay | 95(36.0%) | 61(39.9%) | 156(37.4%) | ||
| Bisexual | 168(63.6%) | 92(60.1%) | 260(62.4%) | ||
| WHO Stage | 0.65 | 0.07 | |||
| Stage 1 | 222(84.1%) | 130(85.0%) | 352(84.4%) | ||
| Stage 3–4 | 25(9.5%) | 17(11.1%) | 42(10.1%) | ||
| Missing | 17(6.4%) | 6(3.9%) | 23(5.5%) | ||
| Incidence | 0.74 | 0.25 | |||
| Prevalent Cases | 239(90.5%) | 137(89.5%) | 376(90.2%) | ||
| Incident Cases | 25(9.5%) | 16(10.5%) | 41(9.8%) | ||
| Sexual Position | 0.01 | 0.43 | |||
| Insertive | 43(16.3%) | 13(8.5%) | 56(13.4%) | ||
| Receptive | 56(21.2%) | 53(34.6%) | 109(26.1%) | ||
| Versatile | 162(61.4%) | 86(48.6%) | 248(59.5%) | ||
| Missing | 3(1.1%) | 1(0.7%) | 5(1.0%) | ||
| Subtypes | 0.10 | 0.03 | |||
| A1 | 2(0.8%) | 4(2.6%) | 6(1.4%) | ||
| CRF02_AG | 154(58.3%) | 90(58.8%) | 244(58.5%) | ||
| CRF02_AG recombinant | 13(4.9%) | 4(2.6%) | 17(4.1%) | ||
| CRF02_AG/B recombinant | 21(8.0%) | 11(7.2%) | 32(7.7%) | ||
| CRF02_AG/G recombinant | 17(6.4%) | 9(5.9%) | 26(6.2%) | ||
| G | 38(14.4%) | 15(9.8%) | 53(12.7%) | ||
| G-containing recombinant | 1(0.4%) | 5(3.3%) | 6(1.4%) | ||
| Others | 18(6.8%) | 15(9.8%) | 33(7.9%) | ||
| CD4 Count(cells/mm3) | 0.52 | 0.76 | |||
| >=500 | 45(17.1%) | 29(19.0%) | 74(17.8%) | ||
| 350–449 | 63(23.5%) | 44(28.8%) | 106(25.4%) | ||
| 201–349 | 72(27.3%) | 41(26.8%) | 113(27.1%) | ||
| <=200 | 82(31.1%) | 39(25.5%) | 121(29.0%) | ||
| Missing | 3(1.1%) | 0(0.0%) | 3(0.7%) | ||
| Continuous | Mean (SD) | Mean (SD) | Mean (SD) | ||
| Viral Load (Log10copies/ml) | 4.61(0.83) | 4.68(0.74) | 4.63(0.79) | 0.38 | <0.01 |
| Missing | 28(10.6%) | 11(7.2%) | 39(9.3%) |
1:
Chi-square p-value was reported excluding
2:
P-value for Rao-Scott Chi-Square test was reported